These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 4828402)
21. [Experiences with adrenaline eye drops in the therapy of glaucoma]. Fechner PU Klin Monbl Augenheilkd; 1966; 148(1):64-78. PubMed ID: 5978087 [No Abstract] [Full Text] [Related]
22. [Role of the sympathetic nervous system in the pathogenesis of experimental glaucoma]. Kryzhanovskiĭ GN; Lipovetskaia EM; Kopp OP Biull Eksp Biol Med; 1980 May; 89(5):535-8. PubMed ID: 6104992 [TBL] [Abstract][Full Text] [Related]
23. [Pharmacological principles of glaucoma therapyAQ]. Fechner PU Buch Augenarzt; 1976; 67(0):86-109. PubMed ID: 985733 [No Abstract] [Full Text] [Related]
24. Influence of an adrenergic potentiator on the ocular response to catecholamines in primates and man. Kitazawa Y; Langham ME Nature; 1968 Sep; 219(5161):1376-8. PubMed ID: 4971171 [No Abstract] [Full Text] [Related]
25. [Recent development in drugs working on ocular autonomic nervous system]. Yoshimura N Nippon Ganka Gakkai Zasshi; 1997 Mar; 101(3):199-200. PubMed ID: 9086736 [No Abstract] [Full Text] [Related]
26. [About the effect of adrenalin-containing eye drops on the intraocular tension in normal and glaucomatous eyes]. Stein HJ Klin Monbl Augenheilkd; 1966; 149(5):725-36. PubMed ID: 5994674 [No Abstract] [Full Text] [Related]
27. [The influence of 2-(1,2,3,4-tetrahydroxy-1-naphthylamino)-2-imidazoline hydrochloride on intraocular pressure and conjunctival hyperemia of the human eye]. Aust W; Rüger K Arzneimittelforschung; 1970 Oct; 20(10):1557-8. PubMed ID: 5536424 [No Abstract] [Full Text] [Related]
32. [Phetanol in primary glaucoma]. Lakomkin VI Vestn Oftalmol; 1973; 5():23-5. PubMed ID: 4798480 [No Abstract] [Full Text] [Related]
33. [Use of adrenalin and other adrenomimetic preparations in primary glaucoma]. Ershkovich IG; Lozovaia GN Oftalmol Zh; 1971; 26(7):489-93. PubMed ID: 5149644 [No Abstract] [Full Text] [Related]
34. Adrenergic supersensitization as a therapeutic tool in glaucoma. Crombie AL Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):570-2. PubMed ID: 4283335 [No Abstract] [Full Text] [Related]
35. Mediation of ocular tetrahydrocannabinol effects by adrenergic nervous system. Green K; Kim K Exp Eye Res; 1976 Oct; 23(4):443-8. PubMed ID: 185078 [No Abstract] [Full Text] [Related]
36. [Adrenaline eye drops in the treatment of glaucoma]. Hilsdorf C; Marxer J Klin Monbl Augenheilkd; 1968 Mar; 152(3):398-404. PubMed ID: 5670396 [No Abstract] [Full Text] [Related]
37. [Nervous regulation of intraocular pressure (review of the literature)]. Astakhov IuS; Bortsov VN Vestn Oftalmol; 1968; 81(1):76-82. PubMed ID: 4392953 [No Abstract] [Full Text] [Related]
38. The ocular effects of epinephrine. Drance SM; Ross RA Surv Ophthalmol; 1970 Jan; 14(4):330-5. PubMed ID: 4906586 [No Abstract] [Full Text] [Related]
39. [Intra-ocular pressure and blood pressure in glaucoma (author's transl)]. Hollwich F MMW Munch Med Wochenschr; 1974 Oct; 116(42):1813-20. PubMed ID: 4215010 [No Abstract] [Full Text] [Related]
40. [Effect of the autonomic nervous system and adaptive hormones (ACTH and cortisone) on the change in intraocular pressure and outflow from the eye following compression]. Shaposhnikova NF Oftalmol Zh; 1966; 21(6):461-4. PubMed ID: 4294339 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]